TUBA4B

gene
On this page

Also known as FLJ13940

Summary

TUBA4B (tubulin alpha 4b, HGNC:18637) is a protein-coding gene on chromosome 2q35, encoding Tubulin-like protein alpha-4B (Q9H853). Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed ofalpha- and beta-tubulin heterodimers.

Predicted to enable GTP binding activity; hydrolase activity; and metal ion binding activity. Predicted to be a structural constituent of cytoskeleton. Predicted to be involved in cytoskeleton organization and microtubule-based process. Predicted to be located in cytoplasm and microtubule.

Source: NCBI Gene 80086 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 3 total
  • Druggable target: yes
  • MANE Select transcript: NM_001355221

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:18637
Approved symbolTUBA4B
Nametubulin alpha 4b
Location2q35
Locus typegene with protein product
StatusApproved
AliasesFLJ13940
Ensembl geneENSG00000243910
Ensembl biotypeprotein_coding
Entrez80086

Gene structure

Transcript identifiers

Ensembl transcripts: 4 — 2 protein_coding_CDS_not_defined, 2 protein_coding

ENST00000473885, ENST00000485041, ENST00000490341, ENST00000713556

RefSeq mRNA: 1 — MANE Select: NM_001355221 NM_001355221

CCDS: CCDS86922

Canonical transcript exons

ENST00000490341 — 4 exons

ExonStartEnd
ENSE00002247466219266521219266566
ENSE00002283895219270202219270335
ENSE00002302786219271166219272197
ENSE00003775756219253243219253419

Expression profiles

Bgee: expression breadth ubiquitous, 190 present calls, max score 97.83.

Top tissues by expression

237 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right uterine tubeUBERON:000130297.83gold quality
epithelium of bronchusUBERON:000203196.31gold quality
bronchial epithelial cellCL:000232895.74gold quality
bronchusUBERON:000218595.67gold quality
oocyteCL:000002395.04gold quality
epithelium of nasopharynxUBERON:000195194.05gold quality
type B pancreatic cellCL:000016992.05gold quality
olfactory bulbUBERON:000226491.68gold quality
nasal cavity epitheliumUBERON:000538491.52gold quality
mucosa of paranasal sinusUBERON:000503090.53gold quality
secondary oocyteCL:000065589.71gold quality
olfactory segment of nasal mucosaUBERON:000538688.77gold quality
diaphragmUBERON:000110386.36gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451184.12silver quality
fallopian tubeUBERON:000388982.94gold quality
oviduct epitheliumUBERON:000480482.74gold quality
gingival epitheliumUBERON:000194982.66silver quality
gluteal muscleUBERON:000200081.94silver quality
hair follicleUBERON:000207381.69gold quality
nasal cavity mucosaUBERON:000182680.52gold quality
gingivaUBERON:000182879.78silver quality
tracheaUBERON:000312679.40gold quality
upper arm skinUBERON:000426376.65silver quality
cervix squamous epitheliumUBERON:000692276.25gold quality
caput epididymisUBERON:000435875.65gold quality
squamous epitheliumUBERON:000691475.12silver quality
amniotic fluidUBERON:000017374.69gold quality
mucosa of urinary bladderUBERON:000125974.40gold quality
deltoidUBERON:000147674.00silver quality
biceps brachiiUBERON:000150773.82silver quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-MTAB-10287yes26.97
E-ANND-3no0.00

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 4)

  • A protein encoded by this locus was found to be differentially expressed in postmortem brains from patients with atypical frontotemporal lobar degeneration. (PMID:22360420)
  • Low expression TUBA4B in NSCLC tissue. (PMID:27411923)
  • The low expression of TUBA4B was significantly associated with poor overall survival, disease-free survival, and recurrence-free survival in cancer patients. (PMID:30157490)
  • Low expression of lncRNA TUBA4B promotes proliferation and inhibits apoptosis of colorectal cancer cells via regulating P15 and P16 expressions. (PMID:32271419)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
danio_reriotuba2ENSDARG00000045014
caenorhabditis_elegansWBGENE00003175

Paralogs (23): TUBG2 (ENSG00000037042), TUBE1 (ENSG00000074935), TUBA3D (ENSG00000075886), TUBB1 (ENSG00000101162), TUBB4A (ENSG00000104833), TUBD1 (ENSG00000108423), TUBA1B (ENSG00000123416), TUBA4A (ENSG00000127824), TUBG1 (ENSG00000131462), TUBB2A (ENSG00000137267), TUBB2B (ENSG00000137285), TUBA3E (ENSG00000152086), TUBA1A (ENSG00000167552), TUBA1C (ENSG00000167553), TUBB8B (ENSG00000173213), TUBB6 (ENSG00000176014), TUBAL3 (ENSG00000178462), TUBA8 (ENSG00000183785), TUBB4B (ENSG00000188229), TUBB (ENSG00000196230), TUBA3C (ENSG00000198033), TUBB3 (ENSG00000258947), TUBB8 (ENSG00000261456)

Protein

Protein identifiers

Tubulin-like protein alpha-4BQ9H853 (reviewed: Q9H853)

Alternative names: Alpha-tubulin 4B

All UniProt accessions (2): Q9H853, A0AAA9YHK8

UniProt curated annotations — full annotation on UniProt →

Function. Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed ofalpha- and beta-tubulin heterodimers.

Subcellular location. Cytoplasm. Cytoskeleton.

Post-translational modifications. Some glutamate residues at the C-terminus are polyglutamylated, resulting in polyglutamate chains on the gamma-carboxyl group. Polyglutamylation plays a key role in microtubule severing by spastin (SPAST). SPAST preferentially recognizes and acts on microtubules decorated with short polyglutamate tails: severing activity by SPAST increases as the number of glutamates per tubulin rises from one to eight, but decreases beyond this glutamylation threshold. Glutamylation is also involved in cilia motility. Some glutamate residues at the C-terminus are monoglycylated but not polyglycylated due to the absence of functional TTLL10 in human. Monoglycylation is mainly limited to tubulin incorporated into cilia and flagella axonemes, which is required for their stability and maintenance. Flagella glycylation controls sperm motility. Both polyglutamylation and monoglycylation can coexist on the same protein on adjacent residues, and lowering glycylation levels increases polyglutamylation, and reciprocally.

Similarity. Belongs to the tubulin family.

RefSeq proteins (1): NP_001342150* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000217TubulinFamily
IPR002452Alpha_tubulinFamily
IPR003008Tubulin_FtsZ_GTPaseDomain
IPR036525Tubulin/FtsZ_GTPase_sfHomologous_superfamily

Pfam: PF00091

Catalyzed reactions (Rhea), 1 shown:

  • GTP + H2O = GDP + phosphate + H(+) (RHEA:19669)

UniProt features (16 total): binding site 8, sequence conflict 3, compositionally biased region 2, chain 1, region of interest 1, active site 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9H853-F171.580.18

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Catalytic / active sites (1): 193

Ligand- & substrate-binding residues (8): 118; 145; 167; 10; 10; 79; 83; 84

Function

Pathways and Gene Ontology

Reactome pathways

79 pathways

IDPathway
R-HSA-1445148Translocation of SLC2A4 (GLUT4) to the plasma membrane
R-HSA-190840Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane
R-HSA-190861Gap junction assembly
R-HSA-2132295MHC class II antigen presentation
R-HSA-2467813Separation of Sister Chromatids
R-HSA-2500257Resolution of Sister Chromatid Cohesion
R-HSA-3371497HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand
R-HSA-380320Recruitment of NuMA to mitotic centrosomes
R-HSA-389960Formation of tubulin folding intermediates by CCT/TriC
R-HSA-389977Post-chaperonin tubulin folding pathway
R-HSA-437239Recycling pathway of L1
R-HSA-5626467RHO GTPases activate IQGAPs
R-HSA-5663220RHO GTPases Activate Formins
R-HSA-6807878COPI-mediated anterograde transport
R-HSA-6811434COPI-dependent Golgi-to-ER retrograde traffic
R-HSA-6811436COPI-independent Golgi-to-ER retrograde traffic
R-HSA-68877Mitotic Prometaphase
R-HSA-8852276The role of GTSE1 in G2/M progression after G2 checkpoint
R-HSA-8955332Carboxyterminal post-translational modifications of tubulin
R-HSA-9609690HCMV Early Events
R-HSA-9609736Assembly and cell surface presentation of NMDA receptors
R-HSA-9619483Activation of AMPK downstream of NMDARs
R-HSA-9646399Aggrephagy
R-HSA-9648025EML4 and NUDC in mitotic spindle formation
R-HSA-9668328Sealing of the nuclear envelope (NE) by ESCRT-III
R-HSA-983189Kinesins
R-HSA-9833482PKR-mediated signaling
R-HSA-109582Hemostasis
R-HSA-112314Neurotransmitter receptors and postsynaptic signal transmission
R-HSA-112315Transmission across Chemical Synapses

MSigDB gene sets: 148 (showing top): AP1_01, REACTOME_ADAPTIVE_IMMUNE_SYSTEM, REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM, LFA1_Q6, AREB6_01, REACTOME_MEMBRANE_TRAFFICKING, GGGTGGRR_PAX4_03, CAGCTG_AP4_Q5, MYOD_01, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, MYCMAX_01, KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN, ARGGGTTAA_UNKNOWN, TGANTCA_AP1_C, NRF2_Q4

GO Biological Process (2): microtubule-based process (GO:0007017), cytoskeleton organization (GO:0007010)

GO Molecular Function (5): structural constituent of cytoskeleton (GO:0005200), GTP binding (GO:0005525), hydrolase activity (GO:0016787), metal ion binding (GO:0046872), nucleotide binding (GO:0000166)

GO Cellular Component (4): microtubule (GO:0005874), cytoplasm (GO:0005737), cytoskeleton (GO:0005856), microtubule cytoskeleton (GO:0015630)

Reactome top-level categories

Rollup of top-17 pathways:

CategoryPathways
Mitotic Prometaphase2
RHO GTPase Effectors2
Golgi-to-ER retrograde transport2
Membrane Trafficking1
Transport of connexons to the plasma membrane1
Gap junction trafficking1
Adaptive Immune System1
Mitotic Anaphase1
Cellular responses to stress1
Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding1
Protein folding1
L1CAM interactions1
ER to Golgi Anterograde Transport1
M Phase1
G2/M Transition1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cytoskeleton2
cellular process1
organelle organization1
structural molecule activity1
cytoskeleton organization1
guanyl ribonucleotide binding1
purine ribonucleoside triphosphate binding1
catalytic activity1
cation binding1
nucleoside phosphate binding1
heterocyclic compound binding1
microtubule cytoskeleton1
polymeric cytoskeletal fiber1
intracellular anatomical structure1
cellular anatomical structure1
intracellular membraneless organelle1

Protein interactions and networks

STRING

2968 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TUBA4BNBEAQ8NFP9460
TUBA4BC11orf16Q9NQ32431
TUBA4BOR1M1Q8NGA1370
TUBA4BTUBGCP2Q9BSJ2348
TUBA4BOR2Z1Q8NG97294
TUBA4BCLXNQ9HAE3277
TUBA4BGARNL3Q5VVW2269
TUBA4BTEKT1Q969V4268
TUBA4BTMEM106AQ96A25265
TUBA4BMYO9AB2RTY4247
TUBA4BNACA2Q9H009246
TUBA4BTUBGCP6Q96RT7225
TUBA4BNOCTQ9UK39225
TUBA4BTUBGCP4Q9UGJ1223
TUBA4BTUBGCP3Q96CW5223
TUBA4BCFAP65Q6ZU64223
TUBA4BZSCAN12O43309223

IntAct

19 interactions, top by confidence:

ABTypeScore
KATNAL1CDK1psi-mi:“MI:0914”(association)0.350
CUL4AHAX1psi-mi:“MI:0914”(association)0.350
CUL3PXDNLpsi-mi:“MI:0914”(association)0.350
CUL5DDX3Xpsi-mi:“MI:0914”(association)0.350
LMYO1Cpsi-mi:“MI:0914”(association)0.350
BMI1MEIS3P1psi-mi:“MI:0914”(association)0.350
IQCB1PCP4L1psi-mi:“MI:0914”(association)0.350
PPP4R1LIFT56psi-mi:“MI:0914”(association)0.350
PRKYMETTL15psi-mi:“MI:0914”(association)0.350
ERBB2DNM1Lpsi-mi:“MI:0914”(association)0.350
STAT3IDH3Bpsi-mi:“MI:0914”(association)0.350
ATF3TMEM223psi-mi:“MI:0914”(association)0.350
FOSTMEM223psi-mi:“MI:0914”(association)0.350
GATA2C11orf98psi-mi:“MI:0914”(association)0.350
CASP3NACApsi-mi:“MI:0914”(association)0.350
FOSC11orf98psi-mi:“MI:0914”(association)0.350
SLC38A1XPOTpsi-mi:“MI:0914”(association)0.350
IKBKGTUBA4Bpsi-mi:“MI:0915”(physical association)0.000

ESM2 similar proteins: A0AAL4, A2AQ07, A6NHL2, P04688, P04689, P06606, P07304, P07436, P08070, P08841, P09207, P09643, P09645, P12460, P20364, P24633, P24634, P25862, P29502, P29514, P31017, P32255, P32256, P32925, P32928, P33624, P33631, P34475, P41385, P41386, P46264, P50260, P50719, P52274, P53371, P53372, P86221, P91910, P92120, Q39697

Diamond homologs: A0A644F0Y1, O49068, O93807, P18695, P23257, P23258, P23330, P25295, P32348, P34785, P34786, P34787, P38557, P38558, P40633, P42271, P53377, P53378, P54401, P54402, P54403, P54404, P54405, P83887, P83888, P90548, Q0VCD2, Q32KM1, Q39582, Q41807, Q41808, Q41874, Q4P235, Q55AR3, Q6DIM3, Q6FNU9, Q75A43, Q7Z9Z2, Q8HZV4, Q8J1R4

SIGNOR signaling

1 interactions.

AEffectBMechanism
ATAT1“up-regulates quantity by stabilization”TUBA4Bacetylation

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 32 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

GO biological processes:

GO termPartnersFoldFDR
intrinsic apoptotic signaling pathway569.0×4e-06
positive regulation of gene expression68.9×4e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

3 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1107 predictions. Top by Δscore:

VariantEffectΔscore
2:219253852:TCA:Tdonor_loss1.0000
2:219253853:CA:Cdonor_loss1.0000
2:219253854:A:ACdonor_gain1.0000
2:219253854:A:Tdonor_loss1.0000
2:219253855:C:CAdonor_loss1.0000
2:219253855:C:CCdonor_gain1.0000
2:219270332:GCTG:Gdonor_gain1.0000
2:219270342:A:Tdonor_gain1.0000
2:219253298:G:GTdonor_gain0.9900
2:219253342:GGTGC:Gdonor_gain0.9900
2:219253854:AC:Adonor_gain0.9900
2:219253855:CC:Cdonor_gain0.9900
2:219253855:CCA:Cdonor_gain0.9900
2:219253855:CCATG:Cdonor_gain0.9900
2:219270329:G:GTdonor_gain0.9900
2:219270334:TGGT:Tdonor_loss0.9900
2:219270336:G:GAdonor_loss0.9900
2:219270336:G:GGdonor_gain0.9900
2:219270337:TGA:Tdonor_loss0.9900
2:219270338:GAG:Gdonor_loss0.9900
2:219253331:C:Gdonor_gain0.9800
2:219253343:GTGC:Gdonor_gain0.9800
2:219253344:TGCT:Tdonor_gain0.9800
2:219253345:GCTG:Gdonor_gain0.9800
2:219253855:CCAT:Cdonor_gain0.9800
2:219270341:G:GTdonor_gain0.9800
2:219271165:GGCT:Gacceptor_gain0.9800
2:219270228:G:Cacceptor_gain0.9700
2:219271164:A:AGacceptor_gain0.9700
2:219271165:G:GGacceptor_gain0.9700

AlphaMissense

1576 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
2:219271193:T:CF74L0.842
2:219271195:C:AF74L0.842
2:219271195:C:GF74L0.842
2:219271295:T:CF108L0.837
2:219271297:C:AF108L0.837
2:219271297:C:GF108L0.837
2:219271520:T:CF183L0.791
2:219271522:T:AF183L0.791
2:219271522:T:GF183L0.791
2:219271394:T:CF141L0.769
2:219271396:C:AF141L0.769
2:219271396:C:GF141L0.769
2:219271202:T:CF77L0.752
2:219271204:C:AF77L0.752
2:219271204:C:GF77L0.752
2:219271553:T:CF194L0.714
2:219271555:C:AF194L0.714
2:219271555:C:GF194L0.714
2:219270219:T:CF26L0.689
2:219270221:C:AF26L0.689
2:219270221:C:GF26L0.689

dbSNP variants (sampled 300 via entrez): RS1000084278 (2:219257378 C>T), RS1000850288 (2:219268687 G>C), RS1000897360 (2:219265239 G>A), RS1000928012 (2:219265566 G>A), RS1000992129 (2:219263004 G>A), RS1001055240 (2:219252410 C>T), RS1001119991 (2:219255694 C>T), RS1001221202 (2:219264013 A>G), RS1001281208 (2:219269016 A>G), RS1001488455 (2:219257931 G>A), RS1001569636 (2:219270332 G>A), RS1001842617 (2:219271910 C>CT), RS1001855611 (2:219257743 G>A), RS1001899535 (2:219266762 G>T), RS1001921760 (2:219252756 C>T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST004616_133Platelet distribution width1.000000e-35
GCST006137_6Serum folate levels5.000000e-06

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0007984platelet component distribution width

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL4295944 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

13 total (human), top 13 by PubMed support.

ChemicalActions (top 5)PubMed papers
Aflatoxin B1affects expression, increases expression4
Benzo(a)pyreneincreases expression3
lasiocarpineincreases expression1
1,6-hexamethylene diisocyanateincreases methylation1
Leflunomidedecreases expression1
Air Pollutantsincreases abundance, increases expression1
Fluorouracilaffects reaction, decreases expression1
Silicon Dioxideincreases expression1
Smokeincreases abundance, increases expression1
Tobacco Smoke Pollutiondecreases expression1
Tretinoinincreases expression1
Valproic Acidincreases expression1
Cyclosporinedecreases expression1

ChEMBL screening assays

1 unique, capped per target: 1 binding

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL4270855BindingBinding affinity to tubulin beta-4B chain in human Hela cells lysates assessed as protein enrichment by measuring normalized heavy/light ratio at by nano-LC-ESIMS/MS analysisDetermination of Gymnemic Acid I as a Protein Biosynthesis Inhibitor Using Chemical Proteomics. — J Nat Prod

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.